Skip to main content

Jeremy Chadwick

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeremy Chadwick

Jeremy Chadwick is recorded as Board Member at Kymera Therapeutics, Inc. (KYMR). Kymera Therapeutics, Inc. reported in an 8-K filed June 8, 2026 that Jeremy Chadwick resigned as Chief Operating Officer, effective June 5, 2026. The proxy statement of Kymera Therapeutics, Inc. reports total compensation of $3,462,173 for Jeremy Chadwick in fiscal 2024, including a base salary of $490,000. Disclosed compensation is on record for 2 fiscal years.

“Jeremy Chadwick communicated his intention to retire and submitted his resignation as Chief Operating Officer (“COO”) on June 5, 2026.”
Kymera Therapeutics, Inc. Form 8-K, filed June 8, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Kymera Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Kymera Therapeutics, Inc. (KYMR) $490,000 $3,462,173
2023 Kymera Therapeutics, Inc. (KYMR) $295,385 $5,001,049

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.